image
GE HealthCare Technologies Inc. GEHC
Healthcare - Medical - Healthcare Information Services - NASDAQ - US
Watchlist
$ 81.76
-1.4 %
$ 37.4 B
Market Cap
22.4
P/E
1. INTRINSIC VALUE

GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, Europe, the Middle East, Africa, China, Taiwan, Mongolia, Hong Kong, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, image-guided therapy, and X-ray systems, as well as women's health products. The Ultrasound segment provides screening, diagnosis, treatment, and monitoring of certain diseases through radiology and primary care, women's health, cardiovascular, and point of care and handheld ultrasound solutions, as well as surgical visualization and guidance products.[ Read More ]

The intrinsic value of one GEHC stock under the base case scenario is HIDDEN Compared to the current market price of 81.8 USD, GE HealthCare Technologies Inc. is HIDDEN

GEHC Intrinsic Value
HIDDEN
SHOW
2. FUNDAMENTAL ANALYSIS

Price Chart GEHC

image
FINANCIALS
19.6 B REVENUE
6.60%
Growth Rates
1Year 6.60%
3Years 4.44%
5Years 0.00%
7Years 0.00%
10Years 0.00%
2.44 B OPERATING INCOME
-3.45%
Growth Rates
1Year -3.45%
3Years -3.62%
5Years 0.00%
7Years 0.00%
10Years 0.00%
1.57 B NET INCOME
-19.55%
Growth Rates
1Year -19.55%
3Years -8.67%
5Years 0.00%
7Years 0.00%
10Years 0.00%
2.1 B OPERATING CASH FLOW
-0.57%
Growth Rates
1Year -0.57%
3Years 7.59%
5Years 0.00%
7Years 0.00%
10Years 0.00%
-558 M INVESTING CASH FLOW
-40.20%
Growth Rates
1Year -40.20%
3Years -0.92%
5Years 0.00%
7Years 0.00%
10Years 0.00%
-478 M FINANCING CASH FLOW
41.85%
Growth Rates
1Year 41.85%
3Years 71.90%
5Years 0.00%
7Years 0.00%
10Years 0.00%
4.86 B REVENUE
0.50%
Growth Rates
1Year 6.60%
3Years 4.44%
5Years 0.00%
7Years 0.00%
10Years 0.00%
676 M OPERATING INCOME
1.81%
Growth Rates
1Year -3.45%
3Years -3.62%
5Years 0.00%
7Years 0.00%
10Years 0.00%
489 M NET INCOME
14.25%
Growth Rates
1Year -19.55%
3Years -8.67%
5Years 0.00%
7Years 0.00%
10Years 0.00%
738 M OPERATING CASH FLOW
720.17%
Growth Rates
1Year -0.57%
3Years 7.59%
5Years 0.00%
7Years 0.00%
10Years 0.00%
-137 M INVESTING CASH FLOW
60.74%
Growth Rates
1Year -40.20%
3Years -0.92%
5Years 0.00%
7Years 0.00%
10Years 0.00%
914 M FINANCING CASH FLOW
1703.51%
Growth Rates
1Year 41.85%
3Years 71.90%
5Years 0.00%
7Years 0.00%
10Years 0.00%
Balance Sheet Decomposition GE HealthCare Technologies Inc.
image
Current Assets 9.41 B
Cash & Short-Term Investments 2.49 B
Receivables 4.25 B
Other Current Assets 2.66 B
Non-Current Assets 23 B
Long-Term Investments 357 M
PP&E 2.5 B
Other Non-Current Assets 20.2 B
Current Liabilities 8.98 B
Accounts Payable 2.95 B
Short-Term Debt 1.12 B
Other Current Liabilities 4.92 B
Non-Current Liabilities 16.2 B
Long-Term Debt 8.75 B
Other Non-Current Liabilities 7.42 B
EFFICIENCY
Earnings Waterfall GE HealthCare Technologies Inc.
image
Revenue 19.6 B
Cost Of Revenue 11.6 B
Gross Profit 7.92 B
Operating Expenses 5.49 B
Operating Income 2.44 B
Other Expenses 867 M
Net Income 1.57 B
RATIOS
40.52% GROSS MARGIN
40.52%
Averages
1Year 40.52%
3Years 40.15%
5Years 39.85%
7Years 0.00%
10Years 0.00%
12.45% OPERATING MARGIN
12.45%
Averages
1Year 12.45%
3Years 14.03%
5Years 14.14%
7Years 0.00%
10Years 0.00%
8.02% NET MARGIN
8.02%
Averages
1Year 8.02%
3Years 10.41%
5Years 10.48%
7Years 0.00%
10Years 0.00%
21.98% ROE
21.98%
Averages
1Year 21.98%
3Years 18.65%
5Years 13.98%
7Years 0.00%
10Years 0.00%
4.83% ROA
4.83%
Averages
1Year 4.83%
3Years 6.78%
5Years 5.76%
7Years 0.00%
10Years 0.00%
10.07% ROIC
10.07%
Averages
1Year 10.07%
3Years 11.48%
5Years 9.66%
7Years 0.00%
10Years 0.00%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis GE HealthCare Technologies Inc.
image
Net Income 1.57 B
Depreciation & Amortization 610 M
Capital Expenditures -387 M
Stock-Based Compensation 114 M
Change in Working Capital -131 M
Others -847 M
Free Cash Flow 1.71 B
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets GE HealthCare Technologies Inc.
image
Wall Street analysts predict an average 1-year price target for GEHC of $96 , with forecasts ranging from a low of $74 to a high of $110 .
GEHC Lowest Price Target Wall Street Target
74 USD -9.49%
GEHC Average Price Target Wall Street Target
96 USD 17.42%
GEHC Highest Price Target Wall Street Target
110 USD 34.54%
4. DIVIDEND ANALYSIS
0.03% DIVIDEND YIELD
0.03 USD DIVIDEND PER SHARE
5. COMPETITION

Teladoc Health, Inc. provides virtual healthcare services in the United States and internationally. The company offers a portfolio of services and solutions covering non-urgent, episodic, chronic, and complicated medical conditions, including diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure, and mental health conditions.

image
42.3 USD
TDOC
Undervalued 359.16%

Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America.

image
291 USD
VEEV
Undervalued 36.47%

10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific.

image
-36.1 USD
TXG
Overvalued 370.91%

Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists.

image
75 USD
PGNY
Undervalued 444.65%

Schrödinger, Inc., together with its subsidiaries, provides physics-based software platform that enables discovery of novel molecules for drug development and materials applications.

image
-23.3 USD
SDGR
Overvalued 225.76%

Doximity, Inc. operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.

image
59.5 USD
DOCS
Undervalued 20.44%

American Well Corporation operates as a telehealth software company that enables digital delivery of care for healthcare. The company products offer urgent care; scheduled visits; acute behavioral health; telestroke; pediatrics; retail health, school health, and home settings.

image
0.00127 USD
AMWL
Overvalued 99.98%

GoodRx Holdings, Inc., through its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States.

image
7.92 USD
GDRX
Undervalued 90.81%
6. Ownership
Insider Ownership GE HealthCare Technologies Inc.
image
Sold
0-3 MONTHS
388 K USD 2
3-6 MONTHS
2.06 M USD 3
6-9 MONTHS
7.11 M USD 1
9-12 MONTHS
0 USD 0
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
101 K USD 1
6-9 MONTHS
0 USD 0
9-12 MONTHS
Date Value Insider Amount Avg Price
1 week ago
Nov 06, 2024
Sell 309 K USD
Rott Roland
CEO, Imaging
- 3577
 86.48 USD
1 week ago
Nov 05, 2024
Sell 78.9 K USD
Rackliffe Philip
CEO, AVS
- 900
 87.63 USD
3 months ago
Aug 14, 2024
Sell 1.58 M USD
Stacherski Kenneth R.
Ch. Supply Chain & Serv. Ofc.
- 19008
 83.22 USD
3 months ago
Aug 07, 2024
Sell 222 K USD
Westrick Thomas J.
CEO, Patient Care Solutions
- 2750
 80.78 USD
5 months ago
May 28, 2024
Sell 260 K USD
Kass-Hout Taha
Chief Technology Officer
- 3300
 78.7 USD
6 months ago
May 13, 2024
Sell 1.65 M USD
Makela Jan
CEO, Imaging
- 20227
 81.57 USD
6 months ago
May 15, 2024
Sell 5.46 M USD
Makela Jan
CEO, Imaging
- 66955
 81.54 USD
6 months ago
May 01, 2024
Bought 101 K USD
Jimenez Frank R
GC & Corporate Secretary
+ 1315
 76.52 USD
1 year ago
Jul 31, 2023
Sell 179 K USD
O'Neill Kevin Michael
CEO, PDx
- 2334
 76.55 USD
1 year ago
Jul 31, 2023
Sell 1.03 M USD
O'Neill Kevin Michael
CEO, PDx
- 13275
 77.46 USD
1 year ago
Jun 08, 2023
Sell 191 K USD
Rott Roland
CEO, Ultrasound
- 2473
 77.37 USD
1 year ago
Jan 23, 2023
Bought 51.8 K USD
CULP H LAWRENCE JR
Director
+ 748
 69.26 USD
1 year ago
Mar 14, 2023
Sell 5.04 M USD
Makela Jan
CEO, Imaging
- 64945
 77.66 USD
1 year ago
Mar 14, 2023
Sell 444 K USD
Makela Jan
CEO, Imaging
- 5684
 78.07 USD
7. News
GE HealthCare and DeepHealth Collaborate to Advance AI in Imaging GEHC and DeepHealth collaborate to develop AI-based imaging tools that can streamline workflow and help manage large imaging volumes without compromising diagnostic accuracy. zacks.com - 1 day ago
GEHC Stock Falls Despite FDA Clearance for SIGNA MAGNUS MRI System GE Healthcare receives FDA clearance for its head-only SIGNA MAGNUS 3.0T MRI System. zacks.com - 2 days ago
RadNet Stock Pops on Earnings, GE HealthCare Partnership Radnet Inc   (NASDAQ:RDNT) stock is soaring, last seen up 24% to trade at $89.11 at last glance, after the company reported better-than-expected earnings and revenue for the third quarter. schaeffersresearch.com - 5 days ago
GE HealthCare and RadNet Forge Collaboration to Transform Imaging Systems and Accelerate the Adoption of Artificial Intelligence (AI) with SmartTechnology™ CHICAGO--(BUSINESS WIRE)--Today, GE HealthCare (Nasdaq: GEHC) and DeepHealth, Inc., a global leader in AI-powered health informatics and a wholly-owned subsidiary of RadNet, Inc. (Nasdaq: RDNT), announced a strategic collaboration to further the innovation, commercialization, and adoption of AI in imaging. Together, the two companies aim to develop SmartTechnology™ solutions that harness the transformative power of AI to address key challenges across the imaging value chain, including helping i. businesswire.com - 5 days ago
GE HealthCare Technologies Inc. Prices Secondary Offering of 13,281,302 Shares CHICAGO--(BUSINESS WIRE)--GE HealthCare Technologies Inc. (Nasdaq: GEHC) (the “Company” or “GE HealthCare”) announced today the pricing of the previously announced secondary underwritten public offering (the “Offering”) of 13,281,302 shares of its common stock (the “GEHC Shares”). GE HealthCare is not selling any shares of common stock and will not receive any proceeds from the sale of the GEHC Shares in the Offering or from the debt-for-equity exchange (as described below). Prior to the closin. businesswire.com - 1 week ago
GE HealthCare Technologies Inc. Commences Secondary Offering of 13,281,302 Shares CHICAGO--(BUSINESS WIRE)--GE HealthCare Technologies Inc. (Nasdaq: GEHC) (the “Company” or “GE HealthCare”) announced today the launch of a secondary underwritten public offering (the “Offering”) of 13,281,302 shares of its common stock (the “GEHC Shares”). GE HealthCare is not selling any shares of common stock and will not receive any proceeds from the sale of the GEHC Shares in the Offering or from the debt-for-equity exchange (as described below). Prior to the closing of the Offering, GE Ae. businesswire.com - 1 week ago
Here's Why GE HealthCare Technologies (GEHC) is a Strong Value Stock The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage. zacks.com - 1 week ago
GE HealthCare: Light Up With Growth Indicators In Medical Tech, While Undervalued GE Healthcare Technologies gets a buy rating, agreeing with today's Wall Street and SA analyst consensus. The firm's recent Q3 results showed growth indicators in multiple segments, despite headwinds from China, and will be crucial in supplying in-demand contrast dyes used in medical imaging. The stock is still undervalued on multiple fronts (EV/EBITDA, P/E), despite the share price trending above its moving average. seekingalpha.com - 1 week ago
Calls of the Day: KLA Corp, Lam Research, ASML Holding, Target and GE Healthcare The Investment Committee debate the latest Calls Of The Day. youtube.com - 2 weeks ago
From Spin-Off To Standout: GE HealthCare Is Pretty Impressive GE HealthCare's spin-off has unlocked valuation potential, allowing each former GE segment to thrive independently and attract market-specific growth. The company's Q3 showed steady revenue and margin gains, driven by operational efficiencies and growth in high-demand medical technologies. With advancements in AI and diagnostics, GE HealthCare is well-positioned to capture market share, though growth faces temporary headwinds in China. seekingalpha.com - 2 weeks ago
GE HealthCare Q3 Earnings Beat Estimates, Sales Meet, Net Margin Up GEHC's third-quarter results witness declining segmental revenues in imaging and ultrasound, offset by strong Pharmaceutical Diagnostics performance. The bottom line improves on better pricing. zacks.com - 2 weeks ago
GE HealthCare Technologies Inc. (GEHC) Q3 2024 Earnings Call Transcript GE HealthCare Technologies Inc. (NASDAQ:GEHC ) Q3 2024 Earnings Conference Call October 30, 2024 8:30 AM ET Company Participants Carolynne Borders - Chief Investor Relations Officer Peter Arduini - President and Chief Executive Officer Jay Saccaro - Vice President and Chief Financial Officer Conference Call Participants Robbie Marcus - J.P. Morgan Ryan Zimmerman - BTIG Joanne Wuensch - Citi David Roman - Goldman Sachs Larry Biegelsen - Wells Fargo Vijay Kumar - Evercore ISI Sezgi Ozener - HSBC Navann Ty - BNP Paribas Operator Thank you for standing by, and welcome to GE HealthCare's Third Quarter 2024 Earnings Conference Call. seekingalpha.com - 2 weeks ago
8. Profile Summary

GE HealthCare Technologies Inc. GEHC

image
COUNTRY US
INDUSTRY Medical - Healthcare Information Services
MARKET CAP $ 37.4 B
Dividend Yield 0.03%
Description GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, Europe, the Middle East, Africa, China, Taiwan, Mongolia, Hong Kong, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, image-guided therapy, and X-ray systems, as well as women's health products. The Ultrasound segment provides screening, diagnosis, treatment, and monitoring of certain diseases through radiology and primary care, women's health, cardiovascular, and point of care and handheld ultrasound solutions, as well as surgical visualization and guidance products. The Patient Care Solutions segment involved in the provision of medical devices, consumable products, services, and digital solutions through patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, and maternal infant care products. The Pharmaceutical Diagnostics supplies diagnostic agents, including CT, angiography and X-ray, MR, single-photon emission computed tomography, positron emission tomography, and ultrasound to the radiology and nuclear medicine industry. The segment also provides contrast media pharmaceuticals, administered to a patient prior to certain diagnostic scans to increase the visibility of tissues or structures during imaging exams; and molecular imaging agents, or radiopharmaceuticals, which are molecular tracers labeled with radioisotopes that are injected into a patient prior to a diagnostic imaging scan. The company was incorporated in 2022 and is headquartered in Chicago, Illinois.
Contact 500 West Monroe Street, Chicago, IL, 60661 https://www.gehealthcare.com
IPO Date Dec. 15, 2022
Employees 51000
Officers Mr. Jahid Khandaker Chief Information Officer Mr. James K. Saccaro Vice President & Chief Financial Officer Ms. Carolynne Borders Chief Investor Relations Officer Mr. Peter J. Arduini President, Chief Executive Officer & Director Dr. Taha Kass-Hout M.D., M.S. Chief Science & Technology Officer Mr. Frank R. Jimenez Esq. Vice President, General Counsel & Corporate Secretary Mr. George Andrew Newcomb Controller & Chief Accounting Officer Ms. Rana Strellis Chief Corporate Marketing & Communications Officer Mr. Adam Holton Chief People Officer Mr. Thomas J. Westrick President & Chief Executive Officer of Patient Care Solutions